NCT06909370

Brief Summary

According to the World Health Organization (WHO), 400 million treatable sexually transmitted diseases (STDs) such as syphilis, chlamydia and human papillomavirus (HPV) occur each year in people aged 15-49, mostly in developing countries. As HPV is a sexually transmitted virus, it has been shown to be the most important aetiological factor in cervical cancer in women (99.7%). Vaccination and education of young people about sexuality and STDs are very important in the prevention of HPV. In this respect, the aim of this study was to find out the level of knowledge, concern and awareness of HPV infection among university students and to increase their awareness by informing them about the subject through their peers. The study was conducted as a pre-test and post-test one-group study. The sample of the study consisted of all final year students of Physiotherapy and Rehabilitation (85 students), Nutrition and Dietetics (60 students), Audiology (35 students), Child Development (80 students), Health Management (44 students) and Social Work (45 students) studying in the spring semester of the 2023-2024 academic year. The students were trained by the Gynaecology Nursing Intern student group (9 students) of the Department of Nursing. Data were collected using the Sociodemographic Characteristics Form, the HPV Knowledge Scale and the Human Papilloma Virus Awareness and Concern Level Scale (HPV-FAS). The relevant forms and the consent form were completed by the students before, after and one month after the training.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
127

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started May 2024

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2024

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 15, 2024

Completed
9 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 15, 2025

Completed
12 days until next milestone

First Submitted

Initial submission to the registry

March 27, 2025

Completed
7 days until next milestone

First Posted

Study publicly available on registry

April 3, 2025

Completed
Last Updated

April 3, 2025

Status Verified

March 1, 2025

Enrollment Period

2 months

First QC Date

March 27, 2025

Last Update Submit

March 27, 2025

Conditions

Keywords

HPVpeer educationawareness

Outcome Measures

Primary Outcomes (3)

  • Sociodemographic Characteristics Form

    It consists of nine questions containing sociodemographic data of students, developed by the researchers.

    Through study completion, an average of 6 months

  • HPV Knowledge Scale (HPV-KS)

    The HPV-KS was developed in 2013 by Waller and colleagues to measure individuals' knowledge levels about HPV, the HPV vaccine, and screening tests. The scale examines whether individuals have previously heard about HPV, the HPV vaccine, and HPV screening tests, as well as the extent of their knowledge on these topics. The first subdimension of the HPV-KS consists of 16 items and assesses participants' general knowledge about HPV. The second subdimension includes six items and is related to HPV screening tests. The third subdimension consists of seven items and asks participants to respond to items about the HPV vaccine. The independent subdimension of the HPV-KS has been developed in three different forms for the HPV vaccination program conducted in three different countries. For each item in the HPV-KS, participants are expected to mark "Yes," "No," or "I don't know." The total score obtained from the HPV-KS ranges from 0 to 33.

    Through study completion, an average of 6 months

  • Human Papillomavirus Awareness and Concern Scale (HPV-ACS)

    Developed by Yılmaz Esencan and colleagues (2023), this scale is designed as a five-point Likert-type and consists of 19 items and three subdimensions. The subdimensions of the scale are "Concern about health," "Concern about being excluded," and "Awareness." The scale scores range from a minimum of 0 to a maximum of 76 points. A higher total score indicates a stronger awareness of HPV. The Cronbach's Alpha reliability coefficient of the original scale was determined to be 0.905.

    Through study completion, an average of 6 months

Study Arms (1)

Sleep Hygiene Training

EXPERIMENTAL
Behavioral: peer education

Interventions

peer educationBEHAVIORAL

The training titled "The Effect of Peer Education on Human Papillomavirus (HPV) for Students in the Faculty of Health Sciences on Knowledge, Awareness, and Concern Levels" includes scientific and up-to-date information about HPV transmission methods, prevention, risk factors, treatment methods, and vaccination. The content of the training aims to provide students with accurate information about HPV, as well as highlight the negative health effects of the virus, particularly its association with serious diseases like cervical cancer. The training seeks to increase students' awareness of HPV and help them manage their levels of concern about the virus. Through the peer education method, students were able to interact with each other, thus providing a more effective learning experience.

Sleep Hygiene Training

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • All individuals who are senior students in the Faculty of Health Sciences departments and who agree to participate in the study will be included in the study.

You may not qualify if:

  • Individuals who did not complete the study and did not speak and understand Turkish were excluded from the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Istanbul Aydın University

Istanbul, Türkiye, Turkey (Türkiye)

Location

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
PREVENTION
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Lecturer

Study Record Dates

First Submitted

March 27, 2025

First Posted

April 3, 2025

Study Start

May 1, 2024

Primary Completion

June 15, 2024

Study Completion

March 15, 2025

Last Updated

April 3, 2025

Record last verified: 2025-03

Locations